Suchergebnisse - "Moore, David"

PubPharm (85)

1

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

enthalten in: The New England journal of medicine | 2022

von Nyang'wa, B. | Berry, C. | Kazounis, E. | +116

CommentIn: N Engl J Med. 2022 Dec 22;387(25):2380-2381. - PMID 36546633

2

Interhospital and interindividual variability in secondary prevention : a comparison of outpatients with a history of chronic coronary syndrome versus outpatients with a history of acute coronary syndrome (the iASPIRE Study)

enthalten in: Open heart | 2021

von Curneen, J. | Judge, C. | Traynor, B. | +20

CommentIn: Open Heart. 2021 Aug;8(2):. - PMID 34413242

3

Engineered extracellular vesicles with synthetic lipids via membrane fusion to establish efficient gene delivery

enthalten in: International journal of pharmaceutics | 2020

von Jhan, Y. | Prasca-Chamorro, D. | Palou Zuniga, G. | +4

4

Depression and aging with HIV : Associations with health-related quality of life and positive psychological factors

enthalten in: Journal of affective disorders | 2019

von Rooney, A. | Moore, R. | Paolillo, E. | +6

5

Active β-Catenin Signaling in the Small Intestine of Humans During Infancy

enthalten in: Digestive diseases and sciences | 2019

von Dudhwala, Z. | Drew, P. | Howarth, G. | +2

6

Pitch and Duration Pattern Sequence Tests in 7- to 11-Year-Old Children : Results Depend on Response Mode

enthalten in: Journal of the American Academy of Audiology | 2019

von Balen, S. | Moore, D. | Sameshima, K.

7

Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer

enthalten in: Molecular cancer research : MCR | 2018

von Yim, S. | Shim, J. | Shin, J. | +11

8

Substance Use Patterns of Gay and Bisexual Men in the Momentum Health Study

enthalten in: American journal of men's health | 2018

von Roth, E. | Cui, Z. | Wang, L. | +10

9

Positive Psychological Factors are Linked to Successful Cognitive Aging Among Older Persons Living with HIV/AIDS

enthalten in: AIDS and behavior | 2018

von Moore, D. | Fazeli, P. | Moore, R. | +40

10

Bevacizumab for advanced cervical cancer : final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

enthalten in: Lancet (London, England) | 2017

von Tewari, K. | Sill, M. | Penson, R. | +20

CommentIn: Lancet. 2017 Oct 7;390(10103):1626-1628. - PMID 28756904

1
2
3
4
5
6
7
8
9
Nächster »
[9]